Experiments using selective ROCK2 inhibitors in rodent models of kidney disease generally have preventive actions on the disease process, including reducing albuminuria and mesangial sclerosis, as well as decreasing GBM thickness. This evidence concerns the gene ROCK2 and Diffuse mesangial sclerosis.